Revenue
YoY +10.4%$30.7B TTM$7.9B Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
MDLN
$39.47-1.28%
as of close, Nov 13, 2026
☾ AH $39.47 -1.28%
Head-to-head:Compare with BDX or any ticker →
MDLN financial statements
The full income statement, balance sheet, and cash-flow statement for Medline Inc. (MDLN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Financial overview#
Gross profit
YoY +2.7%$7.9B TTM$1.9B Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Operating income
YoY −12.9%$1.7B TTM$500M Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Net income
YoY −38.7%$577M TTM$195M Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Operating cash flow
YoY +61.2%$2.4B TTM$1B Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Capital expenditure
YoY +39.6%$486M TTM$141M Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Free cash flow
YoY +65.2%$1.9B TTM$884M Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares outstanding (point-in-time)
2025-12 1.31B2026-03 1.31B2026-06 1.31B2026-09 1.32B+0.2% over 3 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | |
| Revenue | 28.4B+11.5% | 25.5B+9.8% | 23.2B | |
| 7.52B+7.8% | 6.98B+18.5% | 5.88B | ||
| Cost of revenue | 20.9B+12.9% | 18.5B+6.8% | 17.3B | |
| 5.31B+9.9% | 4.83B+4.2% | 4.63B | ||
| Research & development | 80.0M+19.4% | 67.0M+11.7% | 60.0M | |
| Selling, general & administrative | 4.52B+10.1% | 4.11B+6.2% | 3.87B | |
| Amortization of intangibles | 704M+2.8% | 685M+3.5% | 662M | |
| Provision for credit losses | 54.0M-14.3% | 63.0M+687.5% | 8.00M | |
| Operating income | 2.21B+3.1% | 2.15B+71.7% | 1.25B | |
| Interest expense | 945M-17.4% | 1.14B-5.7% | 1.21B | |
| Interest & investment income | 133M-52.5% | 280M+18.1% | 237M | |
| Other non-operating income | -64.0M-48.8% | -43.0M-4400.0% | 1.00M | |
| Pre-tax income | 1.25B+0.2% | 1.25B+372.0% | 264M | |
| Income tax | 91.0M+97.8% | 46.0M+53.3% | 30.0M | |
| 1.16B-0.3% | 1.16B+397.0% | 234M | ||
| Net income to non-controlling interest | -2.00M | — | — | |
| -$0.01 | — | — | ||
| EPS (basic) | -$0.01 | — | — | |
| Weighted-avg shares (basic) | 810M | — | — | |
| Weighted-avg shares (diluted) | 810M | — | — | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | |
| 10.7B+29.1% | 8.27B | — | ||
| Cash & equivalents | 1.94B+874.4% | 199M-87.4% | 1.58B | |
| Short-term investments | 0.00 | — | — | |
| Accounts receivable | 3.53B+9.8% | 3.22B | — | |
| Inventory | 4.77B+7.0% | 4.46B | — | |
| Other current assets | 438M+10.1% | 398M | — | |
| 38.5B+7.0% | 36.0B | — | ||
| Property, plant & equipment | 4.78B+4.0% | 4.59B | — | |
| Operating lease right-of-use | 432M+12.5% | 384M | — | |
| Goodwill | 8.08B+0.2% | 8.06B+7.1% | 7.53B | |
| Intangible assets | 13.9B-4.6% | 14.6B | — | |
| Deferred tax assets | 583M | 0.00 | — | |
| Other non-current assets | 23.0B-0.4% | 23.1B | — | |
| 2.49B+2.0% | 2.44B | — | ||
| Accounts payable | 961M+10.6% | 869M | — | |
| Accrued liabilities | 1.45B-2.7% | 1.49B | — | |
| Short-term & current debt | 77.0M-1.3% | 78.0M | — | |
| Current lease liability | 66.0M-13.2% | 76.0M | — | |
| 19.2B-1.3% | 19.5B | — | ||
| Long-term debt | 12.5B-24.0% | 16.4B | — | |
| Non-current lease liability | 386M+17.3% | 329M | — | |
| Operating lease liability (total) | 452M+11.6% | 405M | — | |
| Other non-current liabilities | 682M+14.0% | 598M | — | |
| Total non-current liabilities | 16.7B-1.8% | 17.0B | — | |
| 10.7B | — | — | ||
| Preferred stock | 0.00 | — | — | |
| Additional paid-in capital | 10.7B | — | — | |
| Retained earnings | -7.00M | — | — | |
| Accumulated other comprehensive income | 27.0M+145.5% | 11.0M | — | |
| Non-controlling interest | 8.55B | — | — | |
| Total equity incl. non-controlling | 19.3B | — | — | |
| Total liabilities & equity | 38.5B+7.0% | 36.0B | — | |
| Common shares outstanding | 1.31B | — | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | |
| 1.74B-1.4% | 1.77B+5.0% | 1.69B | ||
| Depreciation & amortization | 1.01B+3.5% | 977M+2.7% | 951M | |
| Intangible amortization | 704M+2.8% | 685M+3.5% | 662M | |
| Share-based compensation | 76.0M+24.6% | 61.0M-21.8% | 78.0M | |
| Deferred income taxes | -20.0M+16.7% | -24.0M-4.3% | -23.0M | |
| Change in receivables | 355M+38.7% | 256M+67.3% | 153M | |
| Change in inventory | 264M-51.6% | 545M+222.7% | -444M | |
| Change in payables | 73.0M-31.1% | 106M-22.1% | 136M | |
| -474M+68.3% | -1.49B-378.5% | -312M | ||
| Capital expenditure | 447M+26.3% | 354M+28.7% | 275M | |
| Free cash flow | 1.30B-8.3% | 1.42B+0.4% | 1.41B | |
| Acquisitions | -6.00M-100.5% | 1.13B+6937.5% | 16.0M | |
| Other investing activities | 0.00-100.0% | 3.00M-72.7% | 11.0M | |
| 399M+124.7% | -1.61B-744.5% | -191M | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 33.0M+65.0% | 20.0M | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 23.0M+1050.0% | 2.00M-50.0% | 4.00M | |
| Net change in cash | 1.69B+226.7% | -1.33B-212.6% | 1.19B | |
| Interest paid | 944M-7.6% | 1.02B-9.2% | 1.13B | |
| Income taxes paid | 62.0M-38.6% | 101M+94.2% | 52.0M | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | |
| Market cap | 55.2B | — | — | |
| P/E | 47.6× | — | — | |
| P/S | 1.9× | — | — | |
| P/B | 5.1× | — | — | |
| P/FCF | 42.6× | — | — | |
| Earnings yield | 2.1% | — | — | |
| FCF yield | 2.4% | — | — | |
| Source filing | 10-K | 10-K | 10-K |
CEO pay#
As charts →| Fiscal year | CEO | Total, as reported | Actually paid | Other executives, average | $100 in the stock | $100 in peers |
|---|---|---|---|---|---|---|
| FY2025 | Mr.Boyle | $3.9M | $61.8M | $4.6M | $102.44 | $101.10 |
From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.
About this data
Source: MDLN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MDLN filings on SEC EDGAR → Not investment advice.
Head-to-head:Compare with BDX or any ticker →